Evidence map›Paper›PMID 25898826›Full record

ArticleIn vitro cellular & developmental biology. Animal2015

Synergistic effects of FGF-2 and Activin A on early neural differentiation of human pluripotent stem cells.

Sumiyo Mimura, Mika Suga, Yujung Liu, Masaki Kinehara, Kana Yanagihara, Kiyoshi Ohnuma, Hiroki Nikawa, Miho K Furue

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sumiyo MimuraLaboratory of Stem Cell Cultures, National Institute of Biomedical Innovation, Health and Nutrition, 7-6-8 Saito Asagi, Ibaraki, Osaka, 567-0085, Japan.
Mika SugaLaboratory of Stem Cell Cultures, National Institute of Biomedical Innovation, Health and Nutrition, 7-6-8 Saito Asagi, Ibaraki, Osaka, 567-0085, Japan.
Yujung LiuLaboratory of Stem Cell Cultures, National Institute of Biomedical Innovation, Health and Nutrition, 7-6-8 Saito Asagi, Ibaraki, Osaka, 567-0085, Japan.
Masaki KineharaLaboratory of Stem Cell Cultures, National Institute of Biomedical Innovation, Health and Nutrition, 7-6-8 Saito Asagi, Ibaraki, Osaka, 567-0085, Japan.
Kana YanagiharaLaboratory of Stem Cell Cultures, National Institute of Biomedical Innovation, Health and Nutrition, 7-6-8 Saito Asagi, Ibaraki, Osaka, 567-0085, Japan.
Kiyoshi OhnumaDepartment of Bioengineering, Nagaoka University of Technology, Niigata, 940-2188, Japan.
Hiroki NikawaDepartment of Oral Biology & Engineering, Integrated Health Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, 734-8553, Japan.
Miho K FurueLaboratory of Stem Cell Cultures, National Institute of Biomedical Innovation, Health and Nutrition, 7-6-8 Saito Asagi, Ibaraki, Osaka, 567-0085, Japan. mkfurue@gmail.com.
National Institute of Biomedical Innovation, Health and Nutrition · JPHiroshima University · JPNagaoka University of Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neural differentiation is an important target of human embryonic stem cells, which provide a source for cell-based therapy, developmental biology, and pharmaceutical research. Previous studies revealed that inhibition of the bone morphogenetic protein is required for neural induction from human embryonic stem cells. On the contrary, the functions of fibroblast growth factors and Activin/Nodal signaling are controversial. Fibroblast growth factor-2 and Activin/Nodal pathways exert divergent influences on human embryonic stem cell concerning the maintenance of both pluripotency and cellular differentiation. We hypothesized that the combination of fibroblast growth factor-2 and Activin A at various concentrations synergistically exerts diverse effects on cell differentiation. To determine the effects of fibroblast growth factor-2 and Activin A on cellular differentiation into neural lineages, we examined the expression of neural differentiation markers in human embryonic stem cells treated with fibroblast growth factor-2 and/or Activin A at various concentrations in a growth factor-defined serum-free medium in short-term culture. In this study, we provide evidence that fibroblast growth factor-2 and Activin A synergistically regulated the initiation of human embryonic stem cell differentiation into neural cell lineages even though human embryonic stem cells autonomously differentiate into neural cell lineages.

Indexed as

ActivinsCell DifferentiationCell LineageDose-Response Relationship, DrugDrug SynergismFibroblast Growth Factor 2Gene Expression Regulation, DevelopmentalHumansNeuronsPluripotent Stem Cellsactivin AActivinsFibroblast Growth Factor 2Activin ACell differentiationFGF-2High-throughput assayHuman embryonic stem cellsNeural cell lineage

Identifiers

PMID25898826
OpenAlexW1982678647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.